title: [Effect of Visken therapy on the lymphocyte beta2-adrenoceptor-dependent adenylate cyclase system in essential hypertension].
authors.forename: E V
authors.initials: EV
authors.lastname: Parfenova
authors.forename: T L
authors.initials: TL
authors.lastname: Krasnikova
authors.forename: N A
authors.initials: NA
authors.lastname: Aripova
authors.forename: E G
authors.initials: EG
authors.lastname: D'iakonova
authors.forename: E V
authors.initials: EV
authors.lastname: Bosykh
authors.forename: V P
authors.initials: VP
authors.lastname: Masenko
mesh_terms: D000262:Adenylyl Cyclases / Q000187:drug effects*; D000328:Adult; D006801:Humans; D006973:Hypertension / Q000188:drug therapy* / Q000201:enzymology; D008214:Lymphocytes / Q000187:drug effects* / Q000201:enzymology; D008297:Male; D008875:Middle Aged; D010869:Pindolol / Q000494:pharmacology*; D011943:Receptors, Adrenergic, beta / Q000187:drug effects*
chemical_list: D011943:Receptors, Adrenergic, beta; D010869:Pindolol; D000262:Adenylyl Cyclases
vernacular_title: Vliianie terapii viskenom na beta2-adrenoretseptorzavisimuiu adenilattsiklaznuiu sistemu limfotsitov pri gipertonicheskoĭ bolezni.